08 December 2025
: Case report 
Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report
Unusual clinical course, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction
Alaa Babonji
ABCDEF 1*, Fatima Ahmad Algethmi BDEF 2, Basmah Salman Almutairi BDEF 3, Afnan Alsulami BDEF 4, Adel F. Al-Mrzouki BDEF 5,6,7
DOI: 10.12659/AJCR.949883
Am J Case Rep 2025; 26:e949883
Table 1 Baseline laboratory test results.
| Laboratory test | Patient value | Reference value |
|---|---|---|
| Hemoglobin | 15 | 13–18 mmol/L |
| Platelet count | 294 | 140–400×10/L |
| White blood cell count | 8.3 | 4.4–11×10/L |
| International normalized ratio | 0.9 | 0.8–1.2 |
| Activated partial thromboplastin time | 27.3 | 21–45 s |
| Prothrombin time | 10.2 | 10–15 s |
| Creatinine | 262 | 62–115 mmol/L |
| Alanine aminotransferase | 16 | 10–50 U/L |
| Albumin | 43 | 35–50 g/L |
| Alkaline phosphate | 139.3 | 30–130 U/L |
| Aspartate aminotransferase | 16 | 5–40 U/L |
| Troponin I | 0.2 | ≤0.6 ng/L |
| Hemoglobin A1C | 14.4 | <7 |
| Low-density lipoprotein | 1.9 | <3.36 mmol/L |
| Glucose random | 31.5 | 7–10 mmol/L |
| Glucose fasting | 24.2 | 3.89–5.55 mmol/L |